ROANOKE ASSET MANAGEMENT CORP/ NY – Abbott Laboratories Transaction History
ROANOKE ASSET MANAGEMENT CORP/ NY portfolio value:
$4.40M
portfolio value
ROANOKE ASSET MANAGEMENT CORP/ NY quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.47% | -213 shares | -564K | $96.76 | 45.48K |
| Q2 2022 | share | Decrease | -0.05% | -23 shares | -447K | $108.65 | 45.70K |
| Q1 2022 | share | Decrease | -6.19% | -3.01K shares | -1.44M | $118.36 | 45.72K |
| Q4 2021 | share | Decrease | -0.48% | -233 shares | 1.07M | $141 | 48.74K |
| Q3 2021 | share | Increase | 0.00% | 1 shares | 108K | $117.68 | 48.97K |
| Q2 2021 | share | Increase | +17.10% | 7.15K shares | 666K | $115.05 | 48.97K |
| Q1 2021 | share | Decrease | -0.11% | -45 shares | 428K | $118.49 | 41.82K |
| Q4 2020 | share | Decrease | -1.35% | -575 shares | -35K | $107.81 | 41.87K |
| Q3 2020 | share | Increase | +0.01% | 5 shares | 739K | $106.81 | 42.44K |
| Q2 2020 | share | Decrease | -7.81% | -3.59K shares | 247K | $89.39 | 42.44K |
| Q1 2020 | share | Decrease | -0.57% | -265 shares | -389K | $76.84 | 46.03K |
| Q4 2019 | share | Decrease | -17.73% | -9.97K shares | -687K | $84.23 | 46.30K |
| Q3 2019 | share | Decrease | -1.19% | -675 shares | -81K | $80.81 | 56.28K |
| Q2 2019 | share | Decrease | -0.22% | -125 shares | 227K | $80.92 | 56.95K |
| Q1 2019 | share | Increase | +0.88% | 500 shares | 471K | $76.6 | 57.08K |
| Q4 2018 | share | Decrease | -1.33% | -765 shares | -115K | $68.98 | 56.58K |
| Q3 2018 | share | Increase | +21.82% | 10.27K shares | 1.33M | $69.69 | 57.34K |
| Q2 2018 | share | Decrease | -3.52% | -1.71K shares | -52K | $57.68 | 47.07K |
| Q1 2018 | share | Decrease | -1.30% | -645 shares | 102K | $56.4 | 48.79K |
| Q4 2017 | share | Decrease | -4.70% | -2.44K shares | 53K | $53.46 | 49.43K |
| Q3 2017 | share | Decrease | -6.17% | -3.41K shares | 81K | $49.74 | 51.87K |
| Q2 2017 | share | Decrease | -2.82% | -1.60K shares | 161K | $45.07 | 55.28K |
| Q1 2017 | share | Decrease | -14.21% | -9.42K shares | -21K | $40.93 | 56.89K |
| Q4 2016 | share | Decrease | -1.99% | -1.34K shares | -314K | $35.17 | 66.31K |
| Q3 2016 | share | Decrease | -6.87% | -4.99K shares | 5K | $38.48 | 67.66K |
| Q2 2016 | share | Decrease | -0.32% | -233 shares | -193K | $35.55 | 72.65K |
| Q1 2016 | share | Decrease | -2.76% | -2.06K shares | -317K | $37.6 | 72.88K |